Related Experiment Videos
Angiotensin-converting enzyme gene polymorphism and cardiovascular disease
Clinical Science (London, England : 1979)
|March 5, 1998
Summary
Genetic variations in the angiotensin-converting enzyme (ACE) gene, specifically the DD genotype, may influence cardiovascular disease risk. However, this association appears limited to specific populations and its clinical impact is small.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Pharmacogenomics
Background:
- The renin-angiotensin-aldosterone system is critical for cardiovascular regulation.
- Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers are vital therapies for cardiovascular conditions.
- Polymorphisms in the ACE gene are investigated for their role in cardiovascular disease pathogenesis.
Discussion:
- This review examines the link between ACE gene polymorphisms and cardiovascular disease.
- Evidence suggests the DD genotype may adversely affect certain cardiovascular diseases.
- Associations are geographically and subgroup-specific, with unclear mechanisms.
Key Insights:
- The DD genotype of the angiotensin-converting enzyme gene shows a potential adverse influence on specific cardiovascular diseases.
- This influence is not universal, varying by geographical region and patient subgroups.
- The clinical impact of the DD genotype is modest and manifestations are heterogeneous.
Outlook:
- Further research is needed to elucidate the mechanisms underlying the ACE genotype-cardiovascular disease link.
- Investigating gene-gene interactions may clarify the role of ACE polymorphisms.
- Understanding these genetic factors could refine personalized cardiovascular risk assessment and treatment.